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Abstract: The N-methyl-d-aspartate receptor is an important mediator of the 
behavioral effects of ethanol in the central nervous system. Previous studies 
have demonstrated sites in the third and fourth membrane-associated (M) 
domains of the N-methyl-d-aspartate receptor NR2A subunit that influence 
alcohol sensitivity and ion channel gating. We investigated whether two of 
these sites, Phe-637 in M3 and Met-823 in M4, interactively regulate the 
ethanol sensitivity of the receptor by testing dual substitution mutants at 
these positions. A majority of the mutations decreased steady-state 
glutamate EC50 values and maximal steady-state to peak current ratios 
(Iss/Ip), whereas only two mutations altered peak glutamate EC50 values. 
Steady-state glutamate EC50 values were correlated with maximal glutamate 
Iss/Ip values, suggesting that changes in glutamate potency were attributable 
to changes in desensitization. In addition, there was a significant interaction 
between the substituents at positions 637 and 823 with respect to glutamate 
potency and desensitization. IC50 values for ethanol among the mutants 
varied over the approximate range 100–325 mm. The sites in M3 and M4 
significantly interacted in regulating ethanol sensitivity, although this was 
apparently dependent upon the presence of methionine in position 823. 
Molecular dynamics simulations of the NR2A subunit revealed possible binding 
sites for ethanol near both positions in the M domains. Consistent with this 
finding, the sum of the molecular volumes of the substituents at the two 
positions was not correlated with ethanol IC50 values. Thus, there is a 
functional interaction between Phe-637 and Met-823 with respect to 
glutamate potency, desensitization, and ethanol sensitivity, but the two 
positions do not appear to form a unitary site of alcohol action. 
Ethanol is unusual among the major drugs of abuse in that it 
acts only at high concentrations (in the millimolar range) and that it 
acts on multiple targets in the central nervous system. For the greater 
part of the last century, ethanol was generally believed to produce its 
effects on central nervous system function via nonspecific actions on 
neuronal lipids, but it is now well accepted that the biologically 
important actions of ethanol are due to its interactions with proteins 
(1, 2). Of these proteins, the N-methyl-d-aspartate (NMDA)2 receptor 
is among the most important target sites of ethanol in the central 
nervous system. At relevant concentrations, ethanol inhibits ionic 
current (3), synaptic potentials (4), Ca2+ influx (5, 6), and 
neurotransmitter release (7) mediated by NMDA receptors. Studies of 
the mechanism of this inhibition have shown that it does not involve 
competitive inhibition at the glutamate or glycine binding sites (7–12) 
or interaction with sites for other allosteric modulators (8, 12) or open 
channel block (13, 14) but that it involves changes in NMDA receptor 
gating, notably mean open time and opening frequency (13, 14). 
Thus, ethanol appears to inhibit NMDA receptors via low affinity 
interactions with sites that regulate ion channel gating. Although sites 
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in the intracellular C-terminal domain may modulate both ethanol 
sensitivity of the NMDA receptor (15) and ion channel gating (16–19), 
this domain does not contain the site of ethanol action, since removal 
of this region of the protein does not decrease ethanol inhibition of the 
receptor (20). 
In a previous study, Ronald et al. (21) demonstrated that a 
phenylalanine residue (Phe-639) in the third membrane-associated (M) 
domain of the NMDA receptor NR1 subunit influences alcohol 
sensitivity and shows some characteristics of a site of alcohol action. A 
previous study from this laboratory (22) identified a methionine 
residue (Met-823) in the M4 domain of the NMDA receptor NR2A 
subunit that also influences alcohol sensitivity and that fulfills some of 
the criteria for a site of alcohol action. The methionine in M4, however, 
also profoundly affects the gating behavior of the ion channel (23). We 
have recently shown (24) that the cognate position of NR1(Phe-639) in 
the NR2A subunit, Phe-637, also regulates alcohol sensitivity as well as 
desensitization and agonist potency. Studies in γ-aminobutyric acidA 
and glycine receptors have demonstrated residues in transmembrane 
domains 2 and 3 that form sites of alcohol and anesthetic action (25, 
26). These residues appear to line opposite sides of a binding cavity 
for alcohol and various anesthetics (27), which modulate γ-
aminobutyric acidA and glycine receptor ion channel gating (28) by 
occupying a critical volume (29–33). In the present study, we 
investigated whether Phe-637 and Met-823 in the NR2A subunit could 
form a unitary binding site analogous to that found in γ-aminobutyric 
acidA and glycine receptors. We report here that these sites appear to 
functionally interact in regulation of NMDA receptor function and 
ethanol sensitivity, but they do not appear to form a common site of 
ethanol action. 
Experimental Procedures 
Materials—Ethanol (95%, prepared from grain) was obtained 
from Aaper Alcohol & Chemical Co. (Shelbyville, KY), and all other 
drugs were obtained from Sigma. 
Site-directed Mutagenesis and Transfection—Site-directed 
mutagenesis in plasmids containing NR2A subunit cDNA was 
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performed using the QuikChange kit (Stratagene), and all mutants 
were verified by double strand DNA sequencing. Human embryonic 
kidney 293 (HEK293) cells were transfected with NR1–1a, NR2A, and 
green fluorescent protein at a ratio of 2:2:1 using the calcium 
phosphate transfection kit (Invitrogen). In electrophysiological 
experiments, 100 μm ketamine and 200 μm d-l,2-amino-5-
phosphonovaleric acid were added to the culture medium. Cells were 
used in whole cell patch clamp experiments 15–48 h after transfection. 
Electrophysiological Recording—Whole cell patch clamp 
recording was performed at room temperature using an Axopatch 1D 
or Axopatch 200B (Axon Instruments) amplifier. In ethanol 
concentration-response experiments, electrodes with open tip 
resistances of 3–8 megaohms were used. After establishing whole cell 
mode, series resistances of 5–15 megaohms were obtained. In 
glutamate concentration-response experiments, thin wall glass 
capillaries were used to pull electrodes with open tip resistances of 1–5 
megaohms and series resistances of 2–7 megaohms. In all 
experiments, series resistance was compensated by 80%. Cells were 
voltage-clamped at –50 mV and superfused in an external recording 
solution containing 150 mm NaCl, 5 mm KCl, 0.2 mm CaCl2, 10 mm 
HEPES, 10 mm glucose, and 20 mm sucrose. In glutamate 
concentration-response experiments, the external solution contained 
EDTA (10 μm) to eliminate the fast component of apparent 
desensitization due to high affinity Zn2+ inhibition (34). The external 
solution pH was adjusted to 7.4 with NaOH. The intracellular recording 
solution contained 140 mm CsCl, 2 mm Mg4ATP, 10 mm 1,2-bis(2-
aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid, and 10 mm HEPES. 
The intracellular solution pH was adjusted to 7.2 with CsOH. Solutions 
of agonists and ethanol were applied to cells using a stepper motor-
driven solution exchange apparatus (Warner Instruments, Inc.) and 
600-μm inner diameter square glass tubing. Ethanol concentrations 
greater than 500 mm tended to disrupt the gigaohm seal; thus, 500 
mm was the maximum concentration used in ethanol concentration-
response experiments. In glutamate concentration-response 
experiments, cells were lifted off the surface of the dish to increase the 
speed of the solution exchange. We have shown previously that under 
these conditions, 10–90% rise times for solution exchange are ∼1.5 
ms (23). Concentration-response data were filtered at 2 kHz (8-pole 
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Bessel) and acquired at 5 kHz on a computer by using a DigiData 
interface and pClamp software (Axon Instruments). 
Molecular Modeling and Molecular Dynamics (MD) Simulations—
A model of the transmembrane region of the NR2A subunit of the 
NMDA receptor was built by homology modeling with InsightII 
software from Biosym (now Accelrys; San Diego, CA). Aquaporin 
(Protein Data Bank code 1fqy) served as the template for modeling, 
since the arrangement of its helices with respect to the M2 segment 
was the best of several candidates that were considered. The amino-
terminal domain and the S2 ligand-binding domain of NR2A were 
omitted from the model. A segment between the end of M1 and the 
start of M2 had no counterpart in aquaporin and was created as a helix 
and loop. The initial model was subjected to energy minimization with 
a total of 300 iterations of the steepest descent and conjugate 
gradient algorithms. The AMBER force field was used for all energy 
calculations. The minimized structure then served as a template for 
further refinement of the model. The tilt of the M3 helix was adjusted 
manually to optimize packing with the other transmembrane 
segments. In addition, residues along M1 and M3 were shifted one or 
two positions to account for accessibility data (35, 36). Steric clashes 
were corrected, and the structure was further minimized. 
Binding of ethanol to the model NR2A subunit was evaluated by 
adapting the general Monte Carlo simulation method of Clark et al. 
(37). For the MD simulation, the NR2A subunit was solvated with a 
3.5-Å layer of ethanol, which included 122 solvent molecules. The 
NR2A subunit was fixed during the calculations (AMBER force field): 
2,000 steps (1 fs each) of equilibration and 134,000 steps in the 
trajectory at 323 K. Snapshots were saved every 1,000 steps. Most of 
the ethanol solvent (nearly 90%) dispersed from the protein over the 
course of the simulation; 15 molecules remained bound at the end of 
the run. 
Data Analysis—In concentration-response experiments, IC50 or 
EC50 and n (slope factor) were calculated using the equation, y = 
Emax/1 + (IC50 or EC50/x)n, where y represents the measured current 
amplitude, x is concentration, n is the slope factor, and Emax is the 
maximal current amplitude. Statistical differences among 
concentration-response curves were determined by comparing log 
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transformed EC50 or IC50 values from fits to data obtained from 
individual cells using ANOVA followed by the Dunnett's and Tukey-
Kramer tests. Comparisons among mean values of log EC50, IC50, or 
Iss/Ip for the various mutants were made using correlation analysis, 
and testing for linear relations of these values to amino acid molecular 
volume (determined as described previously (23)) was performed 
using linear regression analysis. 
Results 
Effects of Dual Mutations at Phe-637 and Met-823 on Glutamate 
Potency and Desensitization—In order to investigate whether the sites 
Phe-637 in the M3 domain and Met-823 in the M4 domain of the NR2A 
subunit might interactively regulate the function of the receptor, we 
constructed and tested a series of mutants incorporating dual 
substitutions at these positions. Because only hydrophobic amino acids 
were tolerated at the Met-823 position, we chose to test combinations 
of alanine, tryptophan, and the wild type amino acids methionine and 
phenylalanine at these sites. Fig. 1 shows that all combinations of 
these amino acids that were tested at Phe-637 and Met-823 yielded 
functional receptors and that both glutamate potency and 
desensitization were altered in some of the mutants. Concentration-
response curves for glutamate activation of peak and steady-state 
current in the series of mutants were parallel, indicating that none of 
the mutations significantly altered the Hill coefficient (p > 0.05; 
ANOVA). We have previously reported that individual mutations at 
either Phe-637 or Met-823 can alter glutamate EC50 values (23, 24). 
Of six mutant subunits containing dual substitutions at Phe-637 and 
Met-823, none exhibited altered EC50 values for glutamate activation of 
peak current, whereas four had decreased EC50 values for glutamate 
activation of steady-state current (Fig. 2; p < 0.0001; ANOVA). In 
addition, macroscopic desensitization was increased in the majority of 
these mutants. Values of maximal Iss/Ip for currents activated by 300 
μm glutamate in lifted cells were in the range 0.04–0.4 for most of the 
mutants, compared with a value of 0.66 in the wild type receptor (p < 
0.0001; ANOVA). Previous results from our laboratory have 
demonstrated that for single substitution mutants at NR2A(Met-823), 
observed changes in steady-state glutamate EC50 were attributable to 
changes in desensitization (23). In the present study, we found that 
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there was a significant correlation between steady-state glutamate log 
EC50 and maximal Iss/Ip for the series of mutants (R2 = 0.349, p < 
0.05). 
 
FIGURE 1. 
Glutamate-activated currents in NR2A(Phe-637/Met-823) mutant subunits. A, 
records are currents activated by 1, 10, and 100 μm glutamate in the presence of 50 
μm glycine in lifted cells expressing NR1 and wild type NR2A subunits (F/M) or NR2A 
subunits containing various mutations at Phe-637 and Met-823. One-letter amino acid 
codes are used. B and C, concentration-response curves for glutamate activation of 
peak (B) and steady-state (C) current in lifted cells expressing various dual site 
substitution mutations at NR2A(Phe-637/Met-823). Data are means ± S.E.; error bars 
not visible were smaller than the size of the symbols. Curves shown are the best fits to 
the equation given under “Experimental Procedures.” The fit for the wild type NR2A 
subunit is shown as a dashed line. Plots for single-site mutations are not shown. 
Values for wild type, NR2A(F637A), and NR2A(F637W) are from Ref. 24. 
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FIGURE 2.  
Mutations at NR2A(Phe-637/823) can alter glutamate potency and 
desensitization. A and B, average EC50 values for glutamate activation of peak (A) 
and steady-state (B) current in lifted cells expressing NR1 and wild type NR2A 
subunits (F/M) or NR2A subunits containing various mutations at Phe-637 and Met-
823. *, EC50 values that are significantly different from that for wild type NR1/NR2A 
subunits (*, p < 0.05; **, p < 0.01; ANOVA followed by Dunnett's test). Results are 
means ± S.E. of 5–8 cells. C, average values of maximal steady-state to peak current 
ratio (Iss/Ip) in lifted cells coexpressing NR1 and wild type NR2A subunits (F/M) or 
NR2A subunits containing various mutations at Phe-637 and Met-823. Currents were 
activated by 300 μm glutamate in the presence of 50 μm glycine and 10 μm EDTA. *, 
values that differed significantly from that for wild type NR1a/NR2A subunits (**, p < 
0.01; ANOVA followed by Dunnett's test). Results are means ± S.E. of 5–8 cells. D, 
graph plots values of maximal Iss/Ip versus glutamate log EC50 for steady-state current 
in the series of mutants. Maximal Iss/Ip was significantly correlated with glutamate log 
EC50 for steady-state (R2 = 0.349, p < 0.05) but not peak (R2 = 0.0515, p > 0.05; 
results not shown) current. The line shown is the least-squares fit to the data. Values 
for wild type, NR2A(F637A), and NR2A(F637W) are from Ref. 24. 
Effects of Dual Mutations at Phe-637 and Met-823 on Ethanol 
Sensitivity—We next evaluated the ethanol sensitivity of receptors 
containing various mutations at Phe-637 and Met-823 of the NR2A 
subunit by performing concentration-response analysis. All of the 
mutant receptors tested were inhibited by ethanol (Fig. 3). 
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Concentration-response curves for the mutants were essentially 
parallel to each other, but ethanol IC50 values among the mutants 
varied considerably (p < 0.0001; ANOVA). The largest change in 
ethanol sensitivity was observed in the NR2A(F637W) mutant; 
significant differences from the wild type value were also observed for 
the M823W mutant and for all mutants involving dual substitution of 
alanine and tryptophan. It is possible that changes in receptor 
desensitization could differentially alter ethanol sensitivity of peak and 
steady-state current. Previous results from our laboratory (22, 24), 
however, have shown that ethanol inhibition of peak and steady-state 
current does not differ in single substitution mutants at Phe-637 or 
Met-823 of the NR2A subunit. In the present study, ethanol inhibition 
of peak and steady-state current did not differ in F637A/M823W or 
F637W/M823W subunits, the most highly desensitizing of the dual site 
mutants (repeated measures ANOVA, p > 0.05; results not shown). 
 
FIGURE 3. 
Mutations at NR2A(Phe-637/Met-823) can alter NMDA receptor ethanol 
sensitivity. A, records are currents activated by 10 μm glutamate and 50 μm glycine 
and their inhibition by 100 mm ethanol (EtOH) in cells expressing NR1 and wild type 
NR2A subunits (F/M) or NR2A subunits containing various mutations at Phe-637 and 
Met-823. B, concentration-response curves for ethanol inhibition of glutamate-
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activated current in cells expressing various dual site substitution mutations at 
NR2A(Phe-637/Met-823). Data are means ± S.E. of 5–12 cells; error bars not visible 
were smaller than the size of the symbols. Curves shown are the best fits to the 
equation given under “Experimental Procedures.” The fit for the wild type NR2A 
subunit is shown as a dashed line. Plots for single-site mutations are not shown. C, 
average IC50 values for ethanol inhibition of glutamate-activated current in cells 
expressing NR1 and wild type NR2A subunits (F/M) or NR2A subunits containing 
various mutations at Phe-637 and Met-823. *, EC50 values that are significantly 
different from that for wild type NR1/NR2A subunits (**, p < 0.01; ANOVA followed by 
Dunnett's test). Results are means ± S.E. of 5–12 cells. Values for wild type, 
NR2A(F637A), and NR2A(F637W) are from Ref. 24; values for NR2A(M823A), 
NR2A(M823F), and NR2A(M823W) are from Ref. 22. 
Relation of Ethanol Sensitivity to Receptor Function in Dual 
Mutations at Phe-637 and Met-823—It is possible that the changes in 
ethanol sensitivity we observed in the series of mutants tested might 
be linked to changes in agonist potency and desensitization. 
Correlation analysis revealed that ethanol IC50 values were significantly 
negatively correlated with values for glutamate steady-state IC50 (Fig. 
4; R2 = 0.501, p < 0.05), but not glutamate peak IC50 (R2 = 0.327; p 
> 0.05) or maximal steady-state to peak current ratio (R2 = 0.111; p 
> 0.05). Upon inspection of the graph for the latter, it appeared that 
the value for the NR2A(F637W) mutant subunit was an outlier due to 
the dissociation between steady-state glutamate EC50 and maximal 
Iss/Ip value in this mutant. When the value for the NR2A(F637W) 
mutant was excluded from the analysis, a highly significant negative 
correlation was obtained between maximal Iss/Ip and ethanol IC50 (R2 = 
0.691, p < 0.001). 
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FIGURE 4. 
Ethanol sensitivity of NMDA receptors containing NR2A(Phe-637/Met-823) 
mutant subunits is related to glutamate potency and desensitization. A, the 
graph plots values of log glutamate EC50 for peak (closed circles) and steady-state 
(open circles) current versus log ethanol IC50. Glutamate EC50 was significantly 
negatively correlated with log ethanol IC50 for steady-state (R2 = 0.501, p < 0.01; 
dashed line) but not peak (R2 = 0.327, p > 0.05; solid line) current. The lines shown 
are the least-squares fits to the data. B, the graph plots values of maximal Iss/Ip 
versus log ethanol IC50. These variables were not significantly correlated when the 
value for the NR2A(F637W) mutant was included in the analysis (R2 = 0.111; p > 
0.05; solid line) but were significantly negatively correlated when this value was 
excluded from the analysis (R2 = 0.691; p < 0.001; dashed line). Values for wild type, 
NR2A(F637A), and NR2A(F637W) are from Ref. 24; values for NR2A(M823A), 
NR2A(M823F), and NR2A(M823W) are from Ref. 22. 
Interactions of Phe-637 and Met-823 in Regulation of Glutamate 
Potency, Desensitization, and Ethanol Sensitivity—The effects of 
mutations at Phe-637 and Met-823 on glutamate EC50 and maximal 
Iss/Ip values we observed could indicate that these sites interact with 
each other in some manner to regulate receptor function. To 
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investigate this possibility, we constructed interaction plots and 
analyzed the data using two-way ANOVA (Fig. 5). Although only 2 of 
the 11 mutations significantly altered the glutamate peak EC50 value, 
we observed highly significant effects on glutamate peak EC50 of the 
residues at each position individually (p < 0.0001; ANOVA) as well as 
a highly significant interactive effect (p < 0.0001; ANOVA). In 
addition, we observed significant effects on glutamate steady-state 
EC50 of the residue at each individual position (p < 0.0001; ANOVA), 
and a significant interaction between the two positions (p < 0.0001; 
ANOVA). In contrast, maximal Iss/Ip values were altered by mutations 
at position 823 (p < 0.0001; ANOVA) but not 637 (p > 0.05; ANOVA); 
nevertheless, mutations at both sites interactively regulated maximal 
Iss/Ip (p < 0.0001; ANOVA). 
 
FIGURE 5. 
Positions 637 and 823 in the NR2A subunit interactively regulate NMDA 
receptor function and ethanol sensitivity. A and D, the graphs plot EC50 for 
glutamate activation of peak (A) and steady-state (B) current, maximal Iss/Ip (C), and 
ethanol IC50 (D) versus the substituent at position 823 for the series of mutants at 
NR2A(Phe-637/Met-823). Although the substituent at 637 did not by itself affect 
maximal Iss/Ip values (p > 0.05; ANOVA), there were highly significant effects of the 
substituents at 637 and 823 individually on all other measures (p < 0.0001; ANOVA), 
and highly significant interactions between the substituents at 637 and 823 on all 
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measures (p < 0.0001; ANOVA). Note the departure from parallelism due to the 
values for subunits containing methionine at position 823. 
We also tested whether the substituents at Phe-637 and Met-
823 could interactively regulate ethanol sensitivity. Ethanol IC50 was 
highly dependent upon the residue at each position individually (p < 
0.0001; ANOVA), and the analysis also revealed a highly significant 
interaction between the sites in M3 and M4 in regulation of ethanol 
IC50 (p < 0.0001; ANOVA). This interaction was dependent upon the 
presence of the wild type residue methionine at position 823 in M4, 
since it was no longer significant if the values for subunits with 
methionine at 823 were excluded from the analysis (p > 0.05; 
ANOVA). 
Relation of Molecular Volume of Substituents at Phe-637 and 
Met-823 to NMDA Receptor Ethanol Sensitivity—In the substitution 
mutants at sites Phe-637 and Met-823 in the NR2A subunit, the 
observation that the substituent at one position could alter the effects 
of substituents at the other position on ethanol sensitivity of the 
receptor could indicate that these residues physically interact with 
each other. If these sites lined opposite sides of an ethanol binding 
cavity and if ethanol acted via volume occupation of this pocket, then 
one would predict that there should be a significant linear relation 
between ethanol IC50 and the combined molecular volume of the 
amino acid side chains at the two sites. However, no such relation was 
observed (Fig. 6; R2 = 0.0229; p > 0.05). 
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FIGURE 6. 
Combined molecular volume at 637 and 823 in the NR2A subunit is not 
related to ethanol sensitivity. The graph plots ethanol IC50 versus the sum of the 
molecular volumes (in Å3) of the substituents at positions 637 and 823 for the series 
of mutants at NR2A(Phe-637/Met-823). There was not a significant linear relation 
between ethanol sensitivity and molecular volume at the two sites (R2 = 0.0229, p > 
0.05). 
Molecular Dynamics Simulation of Ethanol Binding to the M 
Domains of the NMDA Receptor NR2A Subunit—To determine whether 
ethanol is likely to bind at sites near Phe-637 and Met-823, we 
constructed a model of the M domains of the NMDA receptor NR2A 
subunit and performed MD simulations. Phe-637 and Met-823 were 
13–14 Å apart and appeared to be most closely oriented toward the 
M2 and M3 domains. The model NR2A subunit was soaked with 
ethanol solvent to saturate possible alcohol binding sites. MD 
simulations were then run in which ethanol was allowed to dissociate 
from these binding sites over the course of the trajectory. Solvent 
molecules that are the last to leave represent the strongest 
interactions. In this model (Fig. 7), ethanol bound to a number of sites 
throughout the M domains, including Phe-637 and Met-823. Although 
the MD simulation did not permit precise quantitation of binding 
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affinity, the affinity of ethanol for Phe-637 and Met-823 was in the top 
10% of all sites. 
 
FIGURE 7. 
A molecular model of the NR2A subunit M domains showing putative binding 
sites for ethanol at positions 637 and 823. A model of the M domains of the NR2A 
subunit was derived by homology modeling and is depicted as a ribbon structure. 
Following solvation with ethanol, MD simulations were run in which the ethanol was 
allowed to diffuse away to identify the most probable binding sites. The M2 segment is 
highlighted in purple, and Met-825 and Phe-637 are shown in light blue. Molecules of 
the ethanol solvent are white. Note that two ethanol molecules (light green) remain 
tightly associated with Phe-637 and Met-823. 
Discussion 
We have previously shown that Phe-637 in M3 and Met-823 in 
M4 of the NR2A subunit influence both receptor function and alcohol 
sensitivity (22–24). In the present study, we observed that the 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Journal of Biological Chemistry, Vol. 283, No. 13 (March 28, 2008): pg. 8250-8257. DOI. This article is © American Society 
for Biochemistry and Molecular Biology and permission has been granted for this version to appear in e-
Publications@Marquette. American Society for Biochemistry and Molecular Biology does not grant permission for this 
article to be further copied/distributed or hosted elsewhere without the express permission from American Society for 
Biochemistry and Molecular Biology. 
16 
 
substituent at either of these positions can alter the influence of the 
substituent at the other position on both receptor function (agonist 
potency and desensitization) and ethanol sensitivity of the receptor. A 
direct interaction, such as hydrogen or hydrophobic bonding, between 
the amino acid side chains at positions 637 and 823, however, appears 
unlikely. The functional interaction depended upon the inclusion of the 
mutant containing the wild type residue, methionine, at position 823 
and tryptophan at position 637, because when the value for this 
mutant was removed, the interaction plots were essentially parallel. 
We have previously reported that this mutant, NR2A(F637W), showed 
a marked decrease in the glutamate EC50 values for both peak and 
steady-state current, apparently due to changes in gating (24). 
Substitution of alanine, phenylalanine, or tryptophan at position 823 
reduced, or in some cases eliminated, this effect. This observation is 
difficult to reconcile with a direct interaction between the side chains at 
these positions. A more probable explanation is that when the wild 
type methionine is present at position 823, it may interact with other 
groups in its environment in a manner that places a conformational 
constraint on the M4 domain, which in turn restricts the conformation 
of the other M domains. This conformational restriction could then 
allow tryptophan substitution at position 637 to produce a substantial 
change in gating. Substitution of methionine with a hydrophobic amino 
acid at 823 may release this constraint, diminishing the effect of 
tryptophan at 637. Recent evidence from a study using cysteine 
substitution in NR1/NR2C NMDA receptors (41) is also not consistent 
with an interaction between positions 637 and 823. In this study, the 
location of the amino acids corresponding to Phe-637 and Met-823 in 
the NR1 and NR2C subunits differed by 6–10 positions within the plane 
of the membrane and thus are not likely to be in close proximity to 
each other. The topology of the M domains derived from homology 
modeling in the present study is also consistent with the view that 
Phe-637 and Met-823 do not directly interact. In this model, Phe-637 
and Met-823 are ∼14 Å apart with the M2 loop sandwiched in between. 
In γ-aminobutyric acidA and glycine receptors, amino acid 
substitutions at critical positions in transmembrane domains 2 and 3 
can alter alcohol and anesthetic potency (25, 26). These residues 
appear to form opposite sides of a cavity that binds alcohol and 
various anesthetics (27). The accessibility and dimensions of this 
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cavity change during ion channel gating (38, 39), and occupation of 
the cavity by an alcohol or anesthetic molecule alters gating of the ion 
channel (28, 38). The potency of various alcohols and anesthetics for 
enhancing agonist-activated currents in these receptors is positively 
correlated with the molecular volume of the alcohol or anesthetic and 
negatively correlated with the molecular volume of the amino acid side 
chain (29–33). The occupation of a critical volume in this cavity by the 
alcohol or anesthetic molecules is thus thought to be responsible for 
their modulation of receptor function. If there were a similar cavity 
between the M3 and M4 domains of the NR2A subunit incorporating 
positions 637 and 823 and if ethanol acted by occupying a critical 
volume to destabilize a conformational change in this cavity associated 
with ion channel gating, one would also predict that the molecular 
volume of the substituents at positions 637 and 823 would be 
correlated with ethanol potency. Although this is the case for 
substitutions at position 823 (22), there is a negative correlation with 
ethanol potency for substitutions at position 637 (24). In the present 
study, there was no relation between the sum of the molecular 
volumes of the substituents and ethanol potency, which may indicate 
that the opposing effects of molecular volume at positions 637 and 
823 negated each other. The results obtained in MD simulations were 
also not consistent with a single site of ethanol action formed by 
positions 637 and 823. Although both Phe-637 and Met-823 contribute 
to ethanol binding sites in this model, these residues are separated by 
an estimated distance of 13–14 Å, which means they are not 
sufficiently close to form a common binding site for a single ethanol 
molecule. Thus, it is more likely that Phe-637 and Met-823 form 
separate sites of alcohol action. 
In previous studies from this laboratory, ethanol potency was 
not related to measures of desensitization for single-site substitution 
mutants at NR2A(Phe-637) (24) or NR2A(Met-823) (22). Ethanol 
potency and maximal glutamate Iss/Ip were not correlated in the 
present study for the entire panel of substitution mutants at both 
positions but were significantly negatively correlated when the value 
for the F637W mutant was excluded. Thus, in mutants other than 
NR2A(F637W), ethanol potency decreased with increases in 
desensitization. The observation that the correlation was vitiated by 
the inclusion of the NR2A(F637W) mutant, which exhibited low 
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desensitization and low ethanol potency, argues against modulation of 
desensitization as the critical factor in the action of ethanol. 
Nevertheless, in light of the observations of an apparent trend toward 
a correlation of ethanol sensitivity and desensitization in our previous 
study (22) and the stabilization of desensitization by ethanol in a non-
NMDA glutamate receptor (40), the results of the present study raise 
the possibility that desensitization may contribute to the action of 
ethanol on NMDA receptors. 
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